ZNTL
Zentalis Pharmaceuticals Llc
2.60$
-4.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.2% | -3.9% | +0.9% | -1.8% | -1.2% | -17.4% | -38.9% | +0.0% | -1.9% | -3.8% | +101.3% | – | |
| – | +0.1% | -7.5% | -1.0% | -18.5% | +202.7% | -79.3% | -3.1% | -23.2% | -35.3% | +2.4% | +100.6% | – | |
| – | +114.9% | -258.8% | – | -151.5% | – | – | -574.8% | – | – | – | – | – | |
| – | +90.1% | -76.9% | +352.5% | -100.0% | – | – | – | – | – | – | +0.0% | – | |
| – | -64.2% | – | -44.0% | +39.9% | -33.1% | +25.4% | -24.9% | -6.8% | +14.6% | -7.5% | +100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | +28.6% | +922.2% | -100.0% | – | -100.0% | – | -4,087.8% | -75.5% | -5.8% | – | |
| – | – | – | -106.7% | – | -270.8% | – | -153.9% | – | -308.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.